Objective-To determine the feasibility and benefit of developing guidelines for managing dyspepsia by consensus between general practitioners (GPs) and specialists and to evaluate their introduction on GPs' prescribing, use of investigations, and referrals.
Introduction
One of the essential components of the cycle of medical audit is establishing criteria of good practice, against which current activity can be measured and to which this activity aspires.'
These criteria may take the form of a management protocol, representing a consensus statement or set of guidelines which attempt to specify the optimum management of a given medical condition. Smith observed that there is no agreement on who should write these guidelines or how they should be used2 but pointed to evidence that clinicians are more likely to follow guidelines if they have played a part in creating them.3 ' On the other hand, time and resources will be wasted in reinventing guidelines for common conditions. One compromise might be the modification of nationally agreed guidelines by local clinicians, who would retain an essential feeling of ownership. The importance of precision, specificity, and efficacy as characteristics of clinical guidelines has been emphasised, but research is now needed to assess the impact of guidelines on clinical practice. '6 Dyspepsia is an important, common condition which has been the subject of vigorous debate over recent years.7`The population prevalence of dyspepsia is about 40%, and a quarter of dyspeptic patients consult general practitioners (GPs).°7 There are wide variations in the management of dyspepsia, in terms of investigation, referral, and prescribing. Local agreement on standards of practice might be expected to lead to more appropriate use of resources and improved health outcomes for patients. The recommendations of an international working party have been used by many clinicians as a basis for management for some time, '2 although primary care physicians were not involved in producing them. In this study we used published information about the management of dyspepsia as the basis for producing management guidelines, agreed by consensus between GPs and specialists, and evaluated the effect of introducing them on prescribing, investigations, and referral for dyspepsia in a randomised controlled trial.
Methods
The study was 
Results

STUDY PRACTICES
Practices were randomised into control and study groups in about equal numbers. In all, 179 out of the 254 eligible GPs agreed to provide information about workload. The final control group therefore consisted of 24 practices, representing 101 GPs, and the study group 21 practices, representing 78 GPs. We continued to collect data about referral, prescribing, and use of investigations for all 254 GPs to ensure that the non-participants did not represent a different group from those taking part. Although information about workload was not available, we were unable to detect notable differences between participants and non-participants.
CONSENSUS MEETINGS
Consensus meetings of GPs, physicians, surgeons, and radiologists were attended by 14(18%) of the 78 eligible GPs in the study group, representing seven (33%/o) of the 21 eligible study practices. Each meeting lasted for about two hours, during which a focused discussion identified areas of agreement and disagreement about the indications for investigation of dyspepsia, the choice and timing of investigations, the use of ulcerhealing agents either before or after investigation, and the importance of identifying patients with a positive diagnosis of irritable bowel syndrome. The consensus statements, which were based both on a review of published work and on considerations of locally available facilities, were reached with little difficulty, and similar recommendations were generated in all the meetings. The specialists' contributions were particularly important in delineating the relative merits of endoscopy (recommended as the best investigation for most patients with dyspepsia) and radiology, while the whole group generated the guidelines for deciding when early investigation was required and for the empirical use of H2-antagonists. The "cut off" age of 50 years for early investigation and the recommendation to prescribe one or two courses of ulcer-healing drugs before investigation in younger patients were supported equally by the GPs and specialists.
REFERRALS
Referrals in the six months after publication and circulation of the guidelines were compared with baseline data collected in the six months previously. Although the number of referrals to medical and surgical outpatient clinics rose overall by 50/n (from 4728 to 4964) between the two periods, a fall in referrals for upper gastrointestinal symptoms was observed in both groups (p<0 01). There were 396 (3-92 per doctor) referrals in the control group and 351 (4 50 per doctor) in the study group during the baseline period, with 288 (2 85) and 308 (3 95) referrals respectively in the study period; none of these differences was significant. About a third of these referrals were requests for endoscopy; although there was a slight fall in the total number of requests for endoscopy this was not significant and there was no difference between the numbers of requests in the control and study groups (table 1) .
INVESTIGATIONS
Significantly fewer upper gastrointestinal barium studies were ordered in the second period; 590 requests for barium swallows and barium meals were made in the first six months and 507 in the second (p<0 05). The number requested in the control and study groups was not significantly different, and there was no evidence that barium meals were being used differently after circulation of the guidelines. Similar numbers of patients aged under 50 were referred for barium studies, the proportion of normal examinations was unchanged, and the proportion of examinations in which a major upper gastrointestinal lesion was identified (peptic ulceration, ulcerative oesophagitis, or cancer) was also unchanged ( We set out to determine whether the introduction of these guidelines had any measurable effect on GPs' referrals to outpatient departments, use of investigations, and prescribing for gastrointestinal symptoms. An unexpected finding was an overall fall in the total number of outpatient referrals for gastrointestinal problems in the face of a general increase in overall referral rates to medical and surgical outpatient departments. We do not have a ready explanation, but it may well be related to patient, general practice, or hospital factors that were not measured as part of this research.
There was no evidence that GPs were making better use of the investigations: just as many patients aged under 50 were referred, the proportion of examinations with normal results was unchanged, and identification rates of major upper gastrointestinal lesions did not increase. These results might have been expected, as major changes in referral and investigation behaviour would imply substantial changes in beliefs and, more importantly, habits; it is possibly overoptimistic to believe that merely circulating documents to GPs will produce such changes. We were asking general practitioners to make two changes in their behaviour in relation to these investigations: to modify their selection of patients for investigation and to review the choice of investigations. Given the longstanding controversy about the relative merits of endoscopy and radiology, the wide range of clinical experience of the GPs in the study, and the contrast between open access radiology and consultant referred endoscopy, it would probably have been unrealistic to have expected major changes in the use of these investigations. Possibly the lack of effect of the guidelines reflected existing good clinical practice in the study practices before their introduction; against this view is the investigation rate in young dyspeptic patients and the wide variations in prescribing and referral behaviour within the practices, which are likely to reflect variations in the quality of practice.
In relation to prescribing, however, a "brakes off" recommendation was contained in the guidelines, for prescribing of ulcerhealing drugs before endoscopy. Low prescribers clearly found the guidelines' endorsement of empirical therapy before investigation appealing, and this behavioural change occurred with relative ease, although prescribing H2-antagonist was not accompanied by a fall in investigation rates.
Studies published subsequently comparing early endoscopy and empirical ulcer-healing therapy suggest that investigation rather than "blind" therapy is most cost effective, '4 15 although the debate is likely to continue. One interpretation of the implications of variations in the use of drugs and investigations follows from this -namely, that GPs who are high (empirical) prescribers and low (late) investigators may be providing care which is as appropriate and clinically effective as low ("rational") prescribers and high (early) investigators. The expectation of a shift towards the mean in all practices might represent an oversimplified view of good practice.
The British Society of Gastroenterology's document on the provision of endoscopic facilities in district general hospitals'6 incorporates some of these Southampton guidelines; other individuals and groups have requested material for consideration and modification to suit their own local and individual requirements. This type of material may not be formally "published" and referenced but it would be helpful if it were collated and made available to groups involved in audit and those requiring guidelines for good practice. Regional health authorities, the Department of Health, the specialist societies, and the royal colleges are all involved in audit and in producing guidelines; it may be appropriate for them to ensure that this information is made accessible. However, Farmer emphasised some problems in GPs' acceptance of "off the peg" guidelines prepared by organisations "with an interest in influencing the care offered to patients with chronic diseases."'17 He underlined the importance of taking into account not only the outcomes for patients but the views of patients themselves in formulating health policies. Eddy suggested that the status of policies should be made clear by classifying them as standards, guidelines, or options, depending largely on the strength of the supporting scientific evidence and the potential for choices between strategies to be made by clinicians and patients.' This reminder of the central position of the patient as consumer of health care is timely, yet the viewpoint which it reflects is entirely compatible with the process for generating guidelines, which begins with a joint review of the clinical evidence by specialists and generalists and ends with the adaptation of guidelines for use according to local conditions and requirements.
As well as underlining the difficulties of translating guidelines into action, this study also indicates some of the problems in determining their outcome. Investigation, referral, and prescribing rates are only proxy measures of the quality of care, yet longer term, patient-centred outcome measures will add to the cost and complexity of evaluation.
This study emphasises the gap between producing documentary information -in this case guidelines, although research publications can be regarded in the same way -and implementation and behavioural change. '9 The key issues of dissemination and implementation are now being addressed centrally, within the Department of Health20 and through the Cochrane Centre, established as part of the NHS research and development programme and with the assembly and dissemination of a register of controlled trials as one of its key functions. 2' This study was supported by the Primary Health Care Development Fund. We thank Smith Kline Beecham for further funding, our colleagues in general practice and the Southampton hospitals who participated in the project, and Jenny Bartholomew and Clare Jenkins for their help with data analysis.
